Revenue

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

With its burn treatment gaining traction and a pivotal wound care drug in late-stage trials, MediWound prepares to make its case to Wall Street.

New research reveals a swift move to AI in accounting, but professionals insist on one condition: technology will assist, not replace, human oversight.

As it celebrates 50 years, SpringGreen is leveraging advanced AI partnerships to redefine lawn care, empowering franchisees and enhancing service.

Boundless Futures Foundation and Ladies Who Launch partner to provide funding and vital resources, creating a new ecosystem for mission-driven female founders.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.

A new network of local recycling facilities aims to solve the e-waste gap for small businesses, boosting data security and domestic materials recovery.

TMD Energy's new director, a capital markets expert, sparks a 6.6% stock gain and speculation of M&A or major fundraising on the horizon.

Profitable and with little debt, this holding company is leveraging a diverse portfolio as it prepares for a major stock market uplist. Here's a closer look.

With a new regulatory chief, Ray Therapeutics accelerates its mission to bring its goggle-free optogenetic therapies for blindness through clinical trials.

Glean's new AI assistant promises to move beyond search to autonomous action, tackling enterprise AI adoption challenges with deep contextual understanding.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

An Indiana firm's implantable pump gains key FDA status, promising a future with less mental burden for Type 1 Diabetes patients. But the road is long.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

Cronos Group enters the premium vape race with its new 'liquid diamonds' PUFFERZ, facing immediate competition in Canada's booming all-in-one market.

With two prestigious Stevie® Awards, Dr. Phone Fix validates its model for standardized, reliable service in a fragmented electronics repair market.

Ceva's AI licensing revenue soared in 2025, securing deals with a top PC OEM and Microchip, signaling a major industry shift to on-device intelligence.

Agricultural supplier Farmmi Inc. stuns with a new AI marketing unit, Bluesage, that signed a global client in just two weeks. Is this the future?

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Valmont Industries posts strong adjusted Q4 earnings, banking on a booming infrastructure segment to counter a deep agricultural slump and fuel growth in 2026.